Search research articles
Contact Us
Filters
Showing results (71-80 of 87) with videos related to
Page
of 9
Sort By:
Plos One
|
October 19, 2017
Prospective, multicenter French study evaluating the clinical impact of the Breast Cancer Intrinsic Subtype-Prosigna® Test in the management of early-stage breast cancers
Delphine Hequet, Céline Callens, David Gentien, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 26, 2022
Survival outcomes after neoadjuvant letrozole and palbociclib versus third generation chemotherapy for patients with high-risk oestrogen receptor-positive HER2-negative breast cancer
Suzette Delaloge, Sylvain Dureau, Véronique D'Hondt, et al.
Current Oncology (Toronto, Ont.)
|
October 27, 2023
Patient Derived Xenografts (PDX) Models as an Avatar to Assess Personalized Therapy Options in Uveal Melanoma: A Feasibility Study
Fariba Nemati, Leanne de Koning, David Gentien, et al.
The Lancet. Oncology
|
September 7, 2015
Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial
Christophe Le Tourneau, Jean-Pierre Delord, Anthony Gonçalves, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 2, 2024
Noninvasive Multicancer Detection Using DNA Hypomethylation of LINE-1 Retrotransposons
Marc Michel, Maryam Heidary, Anissa Mechri, et al.
NPJ Precision Oncology
|
June 24, 2021
A computational method for prioritizing targeted therapies in precision oncology: performance analysis in the SHIVA01 trial
Istvan Petak, Maud Kamal, Anna Dirner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 22, 2018
Capecitabine Efficacy Is Correlated with TYMP and RB1 Expression in PDX Established from Triple-Negative Breast Cancers
Elisabetta Marangoni, Cécile Laurent, Florence Coussy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 22, 2016
Genomic Copy Number Profiling Using Circulating Free Tumor DNA Highlights Heterogeneity in Neuroblastoma
Mathieu Chicard, Sandrine Boyault, Leo Colmet Daage, et al.
International Journal of Cancer
|
March 13, 2019
A large collection of integrated genomically characterized patient-derived xenografts highlighting the heterogeneity of triple-negative breast cancer
Florence Coussy, Leanne de Koning, Marion Lavigne, et al.
The Lancet. Oncology
|
February 25, 2018
A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts
Sarah Huet, Bruno Tesson, Jean-Philippe Jais, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 87) with videos related to
Sort By:
Page
of 9
Plos One
|
October 19, 2017
Prospective, multicenter French study evaluating the clinical impact of the Breast Cancer Intrinsic Subtype-Prosigna® Test in the management of early-stage breast cancers
Delphine Hequet, Céline Callens, David Gentien, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 26, 2022
Survival outcomes after neoadjuvant letrozole and palbociclib versus third generation chemotherapy for patients with high-risk oestrogen receptor-positive HER2-negative breast cancer
Suzette Delaloge, Sylvain Dureau, Véronique D'Hondt, et al.
Current Oncology (Toronto, Ont.)
|
October 27, 2023
Patient Derived Xenografts (PDX) Models as an Avatar to Assess Personalized Therapy Options in Uveal Melanoma: A Feasibility Study
Fariba Nemati, Leanne de Koning, David Gentien, et al.
The Lancet. Oncology
|
September 7, 2015
Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial
Christophe Le Tourneau, Jean-Pierre Delord, Anthony Gonçalves, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 2, 2024
Noninvasive Multicancer Detection Using DNA Hypomethylation of LINE-1 Retrotransposons
Marc Michel, Maryam Heidary, Anissa Mechri, et al.
NPJ Precision Oncology
|
June 24, 2021
A computational method for prioritizing targeted therapies in precision oncology: performance analysis in the SHIVA01 trial
Istvan Petak, Maud Kamal, Anna Dirner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 22, 2018
Capecitabine Efficacy Is Correlated with TYMP and RB1 Expression in PDX Established from Triple-Negative Breast Cancers
Elisabetta Marangoni, Cécile Laurent, Florence Coussy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 22, 2016
Genomic Copy Number Profiling Using Circulating Free Tumor DNA Highlights Heterogeneity in Neuroblastoma
Mathieu Chicard, Sandrine Boyault, Leo Colmet Daage, et al.
International Journal of Cancer
|
March 13, 2019
A large collection of integrated genomically characterized patient-derived xenografts highlighting the heterogeneity of triple-negative breast cancer
Florence Coussy, Leanne de Koning, Marion Lavigne, et al.
The Lancet. Oncology
|
February 25, 2018
A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts
Sarah Huet, Bruno Tesson, Jean-Philippe Jais, et al.
Page
of 9